Researchers from the University of Hong Kong say they have developed a combination therapy that could help patients with an aggressive form of leukaemia achieve remission and become eligible for life-saving bone marrow transplants.
The treatment, called QUIZOM, uses two drugs to target a common genetic mutation known as FLT3 which is found in about 30 percent of acute myeloid leukaemia cases…
阅读更多（Read More）